Home
About
FAQ
History (3)
Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators. Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study.
Co-Principal Investigator
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-Principal Investigator
Overview
researcher role of
Furdui, Cristina
contributes to
Redox Biology and Medicine Training Program